Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/6a4cd0c8-4d16-49ec-9f00-c3984014c762/
ADMA
ADMA Biologics IncSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
3 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
10.8%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 42%
📈
Consistent Earners
✗
🌱
GARP
Rev +11%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
32.0%ile
P/E
11.6×
P/S
3.8×
P/B
4.9×
E/P
0.0865
FCF Yield
0.075
EBITDA/EV
0.108
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
72.00000000
/100 — 1=cheapest
VC2 (Trending Value)
72.00000000
/100
VC3 (Buyback)
72.00000000
/100
P/E of 11.6x places this firmly in deep value territory. FCF yield of 7.5% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
87.0%ile
ROE
0.424
ROA
0.249
Net Margin
0.324
Op Margin
0.401
GPA
0.470
D/E
0.70
Current
6.95
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.110
Earn Growth
-0.200
Stability
0.588
lower=better
Accruals
0.056
lower=better
5yr Consist
No
ROE of 42% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
1.0%ile
6M Return
-59.8%
12M Return
-61.3%
12-1 Mom
-60.4%
Risk-Adj
-1.04
Vol 252d
57.8%
Vol 60d
131.5%
↑ Expanding
Max DD 12M
-61.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -60% signals a downtrend — price is moving against you. Near-term vol (132%) is expanding vs long-term (58%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.27
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
9.4%
Sector Quality %ile
89.0%
P/E z-score
-0.25
P/B z-score
-0.01
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (132%) significantly exceeds 252-day (58%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
56.3% avg (7 factors)
Quality
A
89.2% avg (8 factors)
Momentum
F
0.0% avg (4 factors)
Risk
F
20.4% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.270 | —1 | — | |
| Value %ile | 0.320 | —0 | — | |
| Quality %ile | 0.870 | —1 | — | |
| Momentum %ile | 0.010 | —1 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 1.000 | —1 | — | |
| Volatility | 0.578 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
11.57
Earnings Yield (E/P)
0.0865
Price / Sales
3.75
Price / Book
4.90
Price / Cash Flow
14.90
FCF Yield
7.5%
EBITDA / EV
10.8%
Sales Yield (1/P·S)
0.2585
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
42.4%
Return on Assets
24.9%
Net Margin
32.4%
Operating Margin
40.1%
Gross Profit / Assets
Novy-Marx GPA
47.0%
Debt / Equity
0.70
Current Ratio
6.95
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.056
MomentumPrice trend strength over different horizons
6M Return
-59.8%
12M Return
-61.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-60.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-1.04
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-20.0%
Earnings Stability (CV)
Lower = more stable
0.588
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
72
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
72
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
72
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity